Skip to Content
NCI Formulary
Contact NExT
Show menu
Search this site
Last Updated: 01/30/13

Selected Staff Publications

Olaku, O., Zia, F., Santana, J.M., & White, J.D. (2013). The National Cancer Institute Best Case Series Program: A summary of cases of cancer patients treated with unconventional therapies in India. Integrative Cancer Therapies, ahead of print

Olaku, O. (2013). Addition of certain herbal medicines to chemotherapy may increase survival and quality of life in patients with advanced colorectal cancer. Evidenced-Based Nursing,16(1), 14-15.

Jia, L. (2012). Cancer complementary and alternative medicine research at the US National Cancer Institute. Chinese Journal of Integrative Medicine, 18(5),325-32.

Nakayama, A., Alladin, K.P., Igbokwe, O. & White, J.D. (2011). Systematic Review: Generating Evidence-Based Guidelines on the Concurrent Use of Dietary Antioxidants and Chemotherapy or Radiotherapy. Cancer Investigation, 29(10), 655-667

Olaku, O. & White, J.D. (2011).Herbal therapy use by cancer patients: A literature review on case reports. European Journal of Cancer,47(4), 508-514.

White J. (2010). The Challenge of Rational Development of Complex Natural Products as Cancer Therapeutics. Journal of the National Cancer Institute, 102(12), 834-835.

Zia, F. & White, J.D.(2009). Letter to the Editor. Integrative Cancer Therapies, 2009,8(2),113-114.

Lee C., Zia F., Olaku O., Michie J., White J. (2009). Survey of CAM practitioners regarding cancer management and research. Journal of the Society of Integrative Oncology, 7(1), 26-34.

Smith W.B., Olaku O., Michie J., White J.(2008). Survey of cancer researchers regarding complementary and alternative medicine. Journal of the Society for Integrative Oncology, 16(1), 2-12.

Decker G. & Lee C. (2005). Complementary and Alternative Medicine (CAM) Therapies, Chapter 24, in Yarbro, C.H., Goodman, M., & Frogge, M.H (Eds.), Cancer Nursing Principles and Practice, 6th Ed. Boston: Jones and Bartlett Publishers.

Lee C. (2005). Herbs and cytotoxic drugs: recognizing and communicating potentially relevant interactions. Clinical Journal of Oncology Nursing, 9(4), 481-487.

Buchanan DR, White J.D., O'Mara AM, Kelaghan JW, Smith WB, Minasian LM. (2005). Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: Lessons from the National Cancer Institute Community Clinical Oncology Program experience. Journal of Clinical Oncology, 23(27), 6682-9.

Mikhail I.S., DiClemente RJ, Person S, Davies S, Elliott E, Wingood G, Jolly PE. (2004). Association of complementary and alternative medicines (CAM) with HIV clinical disease among a cohort of women living with HIV/AIDS. Journal of Acquired Immune Deficiency Syndromes,37(3),1415-1422.

Lee C. (2004). Translational research in cancer CAM: the NCI Best Case Series program. Clinical Journal of Oncology Nursing, 8(2), 212-214.

White J.D. (2002). PC SPES – a lesson for future dietary supplement research. Journal of the National Cancer Institute, 94(17),1261-1262.

White J.D. (2002). Complementary and alternative medicine research: a National Cancer Institute perspective. Seminars in Oncology, 29(6), 546-51.